v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities:    
Net income (loss) $ 10,065 $ (6,725)
Adjustments to reconcile net income (loss) to net cash flows from operating activities:    
Depreciation and amortization expense 10,514 8,456
Stock-based compensation expense 28,200 30,344
Amortization of premiums and discounts on marketable securities (133) (242)
Amortization of debt issuance costs 161 161
Non-cash lease costs 4,184 4,014
Provision for excess and obsolete inventory 300 0
Other 59 (8)
Changes in operating assets and liabilities:    
Inventory 204 (782)
Accounts receivable 2,836 949
Other current assets (3,904) (719)
Accounts payable 2,568 2,261
Accrued expenses 854 (792)
Operating lease liabilities (5,680) (844)
Other non-current assets and liabilities, net 69 823
Net cash provided by operating activities 50,297 36,896
Investing activities:    
Purchases of investments (39,659) (43,518)
Sales and maturities of investments 35,161 40,946
Expenditures for property and equipment (5,231) (24,975)
Net cash used in investing activities (9,729) (27,547)
Financing activities:    
Net proceeds from common stock issuance 6,390 12,679
Payments on employees’ behalf for taxes related to vesting of restricted stock unit awards (4,945) (6,648)
Repurchases of common stock (8,547) 0
Other (65) (26)
Net cash (used in) provided by financing activities (7,167) 6,005
Net increase in cash, cash equivalents, and restricted cash 33,401 15,354
Cash, cash equivalents, and restricted cash at beginning of period 100,092 85,049
Cash and cash equivalents at end of period 133,493 100,403
Supplemental disclosure of cash flow information:    
Additions to property and equipment included in accounts payable 2,406 1,128
Common stock repurchased but not yet settled $ 300 $ 0